CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- 4 Grant or award CSO/EVP Disc & Trans Research acquired 100,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, Scientific Strategy & CSO sold 20,000 shares at $15.88 ($317,600)
- 4 Open-market sale Director sold 40,000 shares at $16.68 ($667,200)
- 4 Shares withheld for taxes EVP, Commercial gave up 7,177 shares (to pay taxes)
- 4 Open-market sale EVP, General Counsel & Sec sold 36,000 shares at an average $22.73 ($818,280)
- 4 Shares withheld for taxes EVP, Scientific Strategy & CSO gave up 7,177 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 23,304 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and CFO gave up 8,074 shares (to pay taxes)
- 4 Open-market sale EVP, Commercial sold 40,000 shares at $17.94 ($717,600)
- 4 Shares withheld for taxes EVP and CFO gave up 152,867 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 23,304 shares (to pay taxes)
- 4 Shares withheld for taxes EVP and CFO gave up 8,074 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Scientific Strategy & CSO gave up 7,177 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Counsel & Sec gave up 7,177 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Commercial gave up 7,177 shares (to pay taxes)
- 4 Open-market sale EVP, Commercial sold 18,812 shares at $18.21 ($342,567)
- 4 Grant or award Director acquired 19,575 shares (grant or award)
- 4 Grant or award Director acquired 19,575 shares (grant or award)
- 4 Grant or award Director acquired 19,575 shares (grant or award)
Page 13 of 73 · 1,458 filings